4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol has been researched along with idoxifene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, GM; Foster, AB; Goodman, J; Jarman, M; Leclercq, G; Legros, N; McCague, R | 1 |
| Edwards, KJ; Hardcastle, IR; Houghton, J; Jarman, M; Laughton, CA; Neidle, S; Parr, IB; Potter, GA; Rowlands, MG; Trent, JO | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
3 other study(ies) available for 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and idoxifene
| Article | Year |
|---|---|
Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Cytosol; Estrogen Antagonists; Female; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterus | 1989 |
Rationally designed analogues of tamoxifen with improved calmodulin antagonism.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calmodulin; Cyclic Nucleotide Phosphodiesterases, Type 1; Drug Design; Models, Molecular; Structure-Activity Relationship; Tamoxifen | 1995 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |